Cheryl Blanchard, Ph.D., Zimmer Holdings, Inc.’s former chief science officer, has been appointed CEO of MicroCHIPS, Inc. She also becomes a board member of the company.
She replaces Brad Paddock, who is going to Stryker Spine to be the division’s general manager. Paddock had been MicroCHIP’s interim CEO since December 2013.
MicroCHIPS developed a microchip-based implant to provide daily drug dosing ranging from 6 months to 16 years of therapy. The device can be programmed wirelessly allowing the physician to adjust the dosing for individual patient needs. It is implanted under the skin in a simple outpatient procedure using local anesthesia. MicroCHIPS is currently developing drug delivery devices in women’s health applications for contraception and osteoporosis and in chronic diseases of multiple sclerosis and diabetes.